Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Conroy Kevin T Create: Alert

All | News | Filings
Date FiledTypeDescription
03/08/2023 4 Conroy Kevin T (Director) has filed a Form 4 on Adaptive Biotechnologies Corp
Txns: Granted 14,775 shares @ $0
Granted 23,329 options to buy @ $8.46, valued at $197.4k
03/01/2023 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Sold 10,416 shares @ $61.12, valued at $636.6k
Exercised 13,180 restricted stock units @ $0
Exercised 9,312 restricted stock units @ $0
02/23/2023 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Sold 4,764 shares @ $62.72, valued at $298.8k
Exercised 10,374 restricted stock units @ $0
02/14/2023 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Sold 4,527 shares @ $64.55, valued at $292.2k
Exercised 9,705 rights @ $0
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2022 4 Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 8,994 shares @ $0
Granted 41,006 options to buy @ $0.56, valued at $23k
04/01/2022 4 Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 13,043 shares @ $1.15, valued at $15k
03/18/2022 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Exercised 229,757 options to buy @ $5.7, valued at $1.3M
Exercised 4,612 options to buy @ $21.68, valued at $100k
Exercised 2,253 options to buy @ $44.37, valued at $100k
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2022 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Granted 52,722 restricted stock units @ $0
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2022 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Exercised 31,133 shares @ $78.33, valued at $2.4M
Sold 14,409 shares @ $79.55, valued at $1.1M
Exercised 94,425 options to buy @ $9.07, valued at $856.4k
Exercised 96,758 options to buy @ $10.82, valued at $1M
Exercised 31,133 restricted stock units @ $0
01/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2022 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Granted 6,407 shares @ $0
01/04/2022 4 Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 6,000 shares @ $2.5, valued at $15k
11/03/2021 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Sold 16,922 shares @ $93.88, valued at $1.6M
10/05/2021 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Sold 17,078 shares @ $93.64, valued at $1.6M
10/01/2021 4 Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 2,930 shares @ $5.12, valued at $15k
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2021 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Sold 19,970 shares @ $107.5, valued at $2.1M
07/06/2021 4 Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP
Txns: Sold 7,784 shares @ $123.43, valued at $960.8k
07/01/2021 4 Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 1,805 shares @ $8.31, valued at $15k
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2021 4 Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 1,723 shares @ $8.71, valued at $15k
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy